Cyclosporin A and tacrolimus reduce T‐cell polyfunctionality but not interferon‐γ responses directed at cytomegalovirus
暂无分享,去创建一个
R. Hetzer | F. Kern | H. Volk | H. Lehmkuhl | R. Lachmann | M. Streitz | S. Fuhrmann
[1] M. Boeckh,et al. Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study. , 2010, Blood.
[2] E. Arbustini,et al. Preemptive Therapy for Systemic and Pulmonary Human Cytomegalovirus Infection in Lung Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] F. Kern,et al. T cell response to the cytomegalovirus major capsid protein (UL86) is dominated by helper cells with a large polyfunctional component and diverse epitope recognition. , 2008, The Journal of infectious diseases.
[4] M. Roederer,et al. T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.
[5] C. Gray,et al. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development , 2006, Expert review of vaccines.
[6] M. Heemskerk,et al. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. , 2006, Blood.
[7] M. Roederer,et al. Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer. , 2005, Trends in immunology.
[8] C. Craddock,et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers , 2005, The Journal of experimental medicine.
[9] F. Pereyra,et al. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients , 2004, Current opinion in infectious diseases.
[10] R. Koup,et al. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know , 2004, Nature Medicine.
[11] R. Koup,et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.
[12] L. Picker,et al. Mapping T cell epitopes by flow cytometry. , 2003, Methods.
[13] G. Cathomas,et al. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. , 1999, The Journal of infectious diseases.
[14] S. Riddell,et al. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.